COVID-19 and the Kidneys: An Update

Published on Jul 21, 2020in Frontiers of Medicine in China
· DOI :10.3389/FMED.2020.00423
Claudia Benedetti3
Estimated H-index: 3
(ISMMS: Icahn School of Medicine at Mount Sinai),
Meryl Waldman16
Estimated H-index: 16
(NIH: National Institutes of Health)
+ 2 AuthorsPaolo Cravedi35
Estimated H-index: 35
(ISMMS: Icahn School of Medicine at Mount Sinai)
Sources
Abstract
Novel coronavirus disease 2019 (COVID-19) has become a worldwide emergency health problem. The disease occurs mostly in individuals between 30-79 years of age and 81% of cases are mild. However, it may result in progressive respiratory failure owing to alveolar damage and can be fatal in 3.6% of the cases. Direct viral injury, uncontrolled inflammation, and activation of coagulation and complement cascades are thought to participate in disease pathogenesis. Patients with COVID-19 often display kidney injury, including acute kidney injury, mild proteinuria, hematuria or slight elevation in creatinine, possibly as consequence of renal tropism of the virus and multiorgan failure. The impact of COVID-19 on patients that already have renal impairment, including those with chronic kidney disease, kidney transplant recipients, and individuals on hemodialysis (HD) has not been clearly established yet, but data are reports are accumulating and will be reviewed herein. Currently, there is no specific treatment for COVID-19. Research has revealed several agents that may have potential efficacy against COVID-19, mostly acting as anti-viral and anti-inflammatory drugs. Many of these molecules have demonstrated preliminary efficacy against COVID-19 and are currently being tested in clinical trials.
References124
Newest
#1Vinay Nair (Hofstra University)H-Index: 11
#1Ilaria Gandolfini (University of Parma)H-Index: 8
Last. Ernesto P. Molmenti (Hofstra University)H-Index: 19
view all 10 authors...
Abstract An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that began in Wuhan, China, has spread rapidly and has already taken on pandemic proportions. After China, Italy is the country with the highest number of cases so far (41,035 confirmed cases according to Dipartimento della Protezione Civile as of March 19, and 3,405 deaths). In Northern Italy, where the current prevalence of confirmed cases has surpassed in some areas 2 per 1,000 people, kidney transplant patie...
130 CitationsSource
#1Jay A. Fishman (Harvard University)H-Index: 76
#2Paolo Grossi (University of Insubria)H-Index: 53
Abstract COVID-19 has caused ?closure of all schools and universities throughout Italy cinemas, theaters and discoteques are shut down as well.?(among) the few individuals who are out and about, I notice a lot of elbow bumping rather than both-cheek kissing and greater distance between people as they talk.?the trains between Florence and Rome ?are largely empty.? Lori Heatherington, Florence, Italy
65 CitationsSource
#1Xiaochen Li (HUST: Huazhong University of Science and Technology)H-Index: 10
#2Shuyun Xu (HUST: Huazhong University of Science and Technology)H-Index: 4
Last. Jianping Zhao (HUST: Huazhong University of Science and Technology)H-Index: 23
view all 18 authors...
Abstract Background In December 2019, COVID-19 outbreak occurred in Wuhan. Data on the clinical characteristics and outcomes of patients with severe COVID-19 are limited. Objective The severity on admission, complications, treatment, and outcomes of COVID-19 patients were evaluated. Methods Patients with COVID-19 admitted to Tongji Hospital from January 26, 2020 to February 5, 2020 were retrospectively enrolled and followed-up until March 3, 2020. Potential risk factors for severe COVID-19 were ...
910 CitationsSource
#1Ningfang Lian (Fujian Medical University)H-Index: 5
#2Han-Sheng Xie (Fujian Medical University)H-Index: 4
Last. Qichang Lin (Fujian Medical University)H-Index: 12
view all 6 authors...
Abstract Objectives Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Umifenovir (Arbidol®) is an antiviral drug being used to treat influenza in Russia and China. This study aimed to investigate the effectiveness and safety of umifenovir for COVID-19. Methods A retrospective study was performed in non-ICU Ward in Jinyintan Hospital from February 2, 2020 to March 20, 2020. COVID-19 was confirmed by real-time reverse-transcriptase p...
118 CitationsSource
COVID-19 is novel infectious disease with an evolving understanding of its epidemiology and clinical manifestations. Immunocompromised patients often present atypical presentations of viral diseases. Herein we report a case of a COVID-19 infection in a solid organ transplant recipient, in which the first clinical symptoms were of gastrointestinal viral disease and fever, which further progressed to respiratory symptoms in 48h. In these high risk populations, protocols for screening for SARS-Cov2...
167 CitationsSource
#1Jamie S. Hirsch (Hofstra University)H-Index: 13
#2Jia H. Ng (Hofstra University)H-Index: 4
Last. Jia Hwei Ng (Hofstra University)H-Index: 3
view all 9 authors...
Abstract The rate of acute kidney injury (AKI) associated with patients hospitalized with Covid-19, and associated outcomes are not well understood. This study describes the presentation, risk factors and outcomes of AKI in patients hospitalized with Covid-19. We reviewed the health records for all patients hospitalized with Covid-19 between March 1, and April 5, 2020, at 13 academic and community hospitals in metropolitan New York. Patients younger than 18 years of age, with end stage kidney di...
479 CitationsSource
#1Hua Su (HUST: Huazhong University of Science and Technology)H-Index: 12
#2Ming Yang (HUST: Huazhong University of Science and Technology)H-Index: 1
Last. Chun Zhang (HUST: Huazhong University of Science and Technology)H-Index: 6
view all 11 authors...
Abstract Although the respiratory and immune systems are the major targets of Coronavirus Disease 2019 (COVID-19), acute kidney injury and proteinuria have also been observed. Currently, detailed pathologic examination of kidney damage in critically ill patients with COVID-19 has been lacking. To help define this we analyzed kidney abnormalities in 26 autopsies of patients with COVID-19 by light microscopy, ultrastructural observation and immunostaining. Patients were on average 69 years (19 mal...
765 CitationsSource
#1Rui Wang (WHU: Wuhan University)H-Index: 3
#2Cong Liao (WHU: Wuhan University)H-Index: 2
Last. Hua Shui (WHU: Wuhan University)H-Index: 1
view all 9 authors...
In December 2019, an outbreak of coronavirus disease (COVID-19) due to the novel SARS-CoV-2 virus began in China and spread rapidly worldwide. It is unknown whether hemodialysis patients represent a distinct group of patients with certain characteristics that may make them susceptible to infection or severe disease. In this Case Report, we describe the clinical and epidemiological features of COVID-19 in 201 maintenance hemodialysis patients in Zhongnan Hospital of Wuhan university, including 5 ...
88 CitationsSource
#1Yan Deng (HUST: Huazhong University of Science and Technology)H-Index: 10
#2Wei Liu (HUST: Huazhong University of Science and Technology)H-Index: 111
Last. Hui Guo Liu (HUST: Huazhong University of Science and Technology)H-Index: 3
view all 11 authors...
Background The 2019 novel coronavirus has caused the outbreak of the acute respiratory disease in Wuhan, Hubei Province of China since December 2019. This study was performed to analyze the clinical characteristics of patients who succumbed to and who recovered from 2019 novel coronavirus disease (COVID-19). Methods Clinical data were collected from two tertiary hospitals in Wuhan. A retrospective investigation was conducted to analyze the clinical characteristics of fatal cases of COVID-19 (dea...
378 CitationsSource
#1Robert Verity (Imperial College London)H-Index: 27
#2Lucy C Okell (Imperial College London)H-Index: 47
Last. Neil M. Ferguson (Imperial College London)H-Index: 101
view all 33 authors...
Summary Background In the face of rapidly changing data, a range of case fatality ratio estimates for coronavirus disease 2019 (COVID-19) have been produced that differ substantially in magnitude. We aimed to provide robust estimates, accounting for censoring and ascertainment biases. Methods We collected individual-case data for patients who died from COVID-19 in Hubei, mainland China (reported by national and provincial health commissions to Feb 8, 2020), and for cases outside of mainland Chin...
1,958 CitationsSource
Cited By29
Newest
Source
#1Nazeefah Laher (Trinity College, Dublin)
#2Sara Bocchinfuso (Trinity College, Dublin)
Last. Emma Warren (Trinity College, Dublin)
view all 0 authors...
COVID-19 has spread rapidly around the world and taken over 2.6 million lives. Older adults experience disproportionate morbidity and mortality from the disease because increasing age and the presence of comorbidities are important predictors of negative outcomes. Lasting effects of COVID-19 have been described after recovery from the acute illness despite eradication of the virus from the body. The impact of COVID-19 on a person's biological health post-infection is observed in multiple systems...
Source
#1Zeynab Mohamadi Yarijani (Kermanshah University of Medical Sciences)H-Index: 7
#2Houshang Najafi (Kermanshah University of Medical Sciences)H-Index: 14
Since December 2019, the world was encountered a new disease called coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Although SARS-CoV-2 initially causes lung damage, it also affects many other organs, including the kidneys, and on average, 5-23% of people with COVID-19 develop the symptoms of acute kidney injury (AKI), including elevated blood creatinine and urea, hematuria, proteinuria, and histopathological damages. The exact mechani...
Source
#1Devaraju Kanmaniraja (Albert Einstein College of Medicine)
#2Jessica Kurian (Albert Einstein College of Medicine)H-Index: 6
Last. Jenna Le (Albert Einstein College of Medicine)H-Index: 1
view all 11 authors...
Abstract null null The coronavirus disease 2019 (COVID -19) pandemic caused by the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) has affected almost every country in the world, resulting in severe morbidity, mortality and economic hardship, and altering the landscape of healthcare forever. Although primarily a pulmonary illness, it can affect multiple organ systems throughout the body, sometimes with devastating complications and long-term sequelae. As we move into the second ...
Source
#1Hamid Ceylan (Atatürk University)H-Index: 7
In 2019 coronavirus disease (COVID-19), whose main complication is respiratory involvement, different organs may also be affected in severe cases. However, COVID-19 associated cardiovascular manifestations are limited at present. The main purpose of this study was to identify potential candidate genes involved in COVID-19-associated heart damage by bioinformatics analysis. Differently expressed genes (DEGs) were identified using transcriptome profiles (GSE150392 and GSE4172) downloaded from the ...
Source
Source
Objective null Coronavirus disease 2019 (COVID-19) is an emerging, fast-spreading, highly mortal and worldwide infectious disease. The pulmonary system was defined as the main target of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but the mortality concept of this disease presented with more severe and systemic disease. The present study investigated the relationship between the patient characteristics at the initial hospital administration and fatality in COVID-19 patients. nul...
Source
High-density lipoproteins (HDLs) are a class of blood particles, principally involved in mediating reverse cholesterol transport from peripheral tissue to liver. Omics approaches have identified crucial mediators in the HDL proteomic and lipidomic profile, which are involved in distinct pleiotropic functions. Besides their role as cholesterol transporter, HDLs display anti-inflammatory, anti-apoptotic, anti-thrombotic, and anti-infection properties. Experimental and clinical studies have unveile...
Source
Source
#1Jagmeet P. Singh (The Commonwealth Medical College)H-Index: 56
#2Preeti Malik (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 8
Last. Asim Kichloo (CMU: Central Michigan University)H-Index: 7
view all 14 authors...
We aimed to identify prevalence and association of comorbid chronic kidney disease (CKD), acute kidney injury (AKI) and utilization prevalence of continuous renal replacement therapy (CRRT) in COVID-19-hospitalized patients as a function of severity status. With the ongoing struggle across the globe to combat COVID-19 disease, published literature has described the role of kidney disease in COVID-19 patients based on single/multicenter experiences across the globe. We extracted data from observa...
1 CitationsSource